Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-003285

CHIEF ACCOUNTING OFFICER gave up 1,120 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 3,231 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2022-03-21 Option exercise +3,231 7,161 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2022-03-21 Shares withheld for taxes −1,120 $10.98 $12,298 6,041 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2022-03-21 Option exercise · Restricted Share Unit −3,231 0 D
Loading xslF345X03/form4-03232022_040321.xml…